BioSpace News Archive

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announces the commercial launch of ColoAlert® in Poland, made possible through a strategic collaboration with testDNA Sp. z o. o. Sp. K.

Actimed Therapeutics Ltd announces it has raised a further £4.75m in an extension to its recent Series A financing round which was completed in June this year.

Affimed N.V. announced the publication of a manuscript that demonstrates how the FcRn-pH-HPLC technology can be leveraged to predict PK properties of various ICE® formats built on the ROCK® platform.

Shoulder Innovations Inc., a Grand Rapids, Michigan-based leader in the shoulder replacement implant market, announced securing of a $45M debt facility in partnership with Trinity Capital.

LAVA Therapeutics N.V. today announced recent corporate highlights and financial results for the quarter ended June 30, 2023.

Regenesis Biomedical, Inc., a medical device company focused on safe, non-drug, pain management, announced today commercialization of the new Reprieve by Regenesis™ device (Reprieve).

Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) (“the Company”) today provided an update on injection kits supplied by Apellis and an update on the rare events of retinal vasculitis reported in real-world treatment with SYFOVRE® (pegcetacoplan injection) for geographic atrophy (GA) secondary to age-related macular degeneration (AMD).

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), a clinical-stage biotechnology company developing novel therapies for the treatment of ophthalmic diseases

Marvel Biosciences Corp. (TSXV: MRVL) (OTCQB: MBCOF) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), is pleased to announce that it has successfully completed its 4-week

Justera Health Ltd. (CSE: VTAL) (OTC Pink: SCRSF) (formerly ScreenPro Security Inc.) (“Justera” or the “Company”) is pleased to announce its intention to complete a non-brokered private placement